Generic versions of Forxiga’s salt-modified drug, which were released in April, will be reimbursed from next month.

These generics were released later than other Forxiga generics because the original salt-modified drug obtained first generic exclusivity in Korea, banning the sales of other salt-modified drugs that contain the same ingredient until January 7 next year.

According to industry sources on the 19th, Foxiga’s salt-modified generics, including Samjin Pharamcetucial’s Dapozin Tab 5mg, Kyungbo Pharm’s Dapakhan Tab 10mg, will be listed next month

Fixe single-agent and 8 combination drugs will be listed at the time.

Samjin Pharamcetucial’s D